Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Brodt is a Clinical Associate Professor at Stanford University, engaged in clinical care, teaching and research in cardiothoracic anesthesiology. Dr. Brodt is on the SCA Board of Directors and founded the SCA Regional Anesthesia for Cardiothoracic Enhanced Recovery (RACER) Special Interest Group, in addition to serving on multiple SCA committees and task forces. As the recipient of the 2019 SCA-IARS Mid-Career Research Grant, Dr Brodt is pursuing evidence for the utility of regional anesthesia for enhanced recovery in cardiac surgery patients (the RACER study), and continuously seeks to advance the application of regional techniques to a variety of surgical procedures in the population we care for. This stems from a drive to find effective and safe analgesia for cardiac surgery. Dr. Brodt has presented on regional anesthesia for cardiac surgery, considerations for perioperative opioid use, and other topics in cardiac anesthesia at conferences including ASA, SCA, ACA, ERAS Cardiac Society, EACTAIC, moderated the SCA’s first ever international webinar, and is an Editor for the Journal of Cardiothoracic and Vascular Anesthesia. Dr. Brodt is a strong advocate for work-life harmony, and is a proud mom to 4 inspiring children.
Clinical EducationRegional Anesthesia for Cardiothoracic Enhanced Recovery (RACER)Anesthesia for transcatheter and electrophyiology procedures
Regional Anesthesia for Cardiothoracic Enhanced Recovery
The erector spinae plane block (ESPB) is a novel regional analgesic technique that provides
pain relief with a peripheral nerve block catheter. The goal of this study is to see if
bilateral ESPB catheters can improve clinical outcomes in patients undergoing cardiac surgery
via sternotomy, such as decreasing the duration of postoperative mechanical ventilation, need
for intravenous opioid medications, length of stay in the intensive care unit (ICU), and
improving pain scores.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details